Overview
Trigeminal neuralgia is a chronic facial pain condition caused by irritation of the trigeminal nerve, also known as cranial nerve V.[6][8]
The trigeminal nerve carries sensation from your face, jaw, gums, and teeth to the brain. When this nerve fires incorrectly, it produces sudden bursts of severe pain. Each attack feels like an electric shock pain or stabbing pain and lasts from a few seconds to about two minutes.[6][8] Almost all attacks affect one side of the face, a feature called unilateral pain.
Trigeminal neuralgia is uncommon but not rare. Older studies estimated 4 to 13 cases per 100,000 person-years, while larger UK and US population studies extend the upper range to 26.8 to 29 per 100,000 person-years. A pooled global analysis put the incidence at about 25.3 per 100,000 person-years.[6][8][15] The mean age of onset is 53 to 57, and incidence rises sharply in older adults, peaking at over 23 per 100,000 in those above age 80, and reaching as high as 45.2 per 100,000 in men over 80. The female-to-male ratio is roughly 1.5:1 to 3:1.[6][8] The pain often starts in the cheek or jaw, which is why many patients are first misdiagnosed as TMJ or a dental problem.[9][10]
Living with trigeminal neuralgia can be exhausting. Research has linked the condition to higher rates of depression, anxiety, and even dementia, likely because of long-term pain and disrupted sleep.[4]
Causes and Risk Factors
Most cases happen when a blood vessel presses on the trigeminal nerve near the brainstem, but several other conditions can also damage the nerve.[6][8]
When the nerve is compressed or injured, its protective coating, called the myelin sheath, breaks down at the root entry zone where the nerve meets the brainstem. This demyelination causes the nerve to misfire and send pain signals without a normal trigger, a process sometimes called the ignition hypothesis.[6][8]
Vascular Compression
In classic trigeminal neuralgia, an artery loops over the trigeminal nerve where it leaves the brainstem. About 64% of compressing vessels are arteries, and within that group the superior cerebellar artery is the culprit in roughly 81% of cases. Across all cases of classic trigeminal neuralgia, the superior cerebellar artery accounts for an estimated 75% to 80% of vascular compressions.[8] The pulsing vessel slowly wears down the nerve coating and irritates the trigeminal ganglion, the nerve's main relay station.[6][8] Pain most often radiates along the maxillary (V2) or mandibular (V3) branches, with combined V2/V3 involvement reported in about 35% of patients, which is part of why dental causes are so often suspected first.[8][10] Vascular compression is the most common reason for the condition in adults.
Multiple Sclerosis and Demyelination
Multiple sclerosis can cause demyelination directly inside the central nervous system. About 1% to 5% of people with MS develop trigeminal neuralgia, and people with MS have roughly a 20-fold higher risk of trigeminal neuralgia than the general population.[2][6][8] MS patients also tend to present at a younger age (often under 40) and are more likely to have bilateral trigeminal neuralgia, with bilateral involvement reported in 18% to 30% of MS-related cases.[2][8] This is called secondary trigeminal neuralgia.
Treatment is often harder in MS patients because the demyelinating plaques sit inside the brainstem rather than at the nerve root. Some MS patients also have both a brainstem plaque and a vascular compression at the same time, sometimes called a double-crush mechanism, which can mask the central cause on imaging.[2][8] Patients with MS who undergo microvascular decompression also experience significantly lower long-term success rates than patients with classic trigeminal neuralgia. Pain relief is reported in only about 50% of MS patients at 2 years post-surgery, and some meta-analyses report long-term pain-free outcomes in the 30% to 50% range, well below the rates seen in classic trigeminal neuralgia.[2] This caveat matters when MS patients weigh the risks of open brain surgery against the expected benefit.
Tumors and Other Causes
A tumor near the cranial nerve V pathway, a stroke or infarct in the brainstem, or rare conditions like neurotrophic keratitis can also disturb the nerve and trigger pain.[1][5] These less common causes are why imaging is important during diagnosis.
Risk Factors
Risk factors include being over the age of 50, female sex, and a family history of the condition. Hypertension has been linked to higher rates of trigeminal neuralgia in some studies, possibly because long-standing hypertension can change blood vessel shape over time. Tortuosity and elongation of cerebral arteries (called dolichoectasia) may then increase contact with the trigeminal nerve.[6][8]
Symptoms and Diagnosis
Trigeminal neuralgia causes sudden, severe facial pain on one side, often set off by light touch, chewing, or a breeze on the cheek.[6]
Pain Characteristics
Patients describe the pain as stabbing pain, lancinating pain, or like an electric shock pain. The International Classification of Headache Disorders (ICHD-3) defines each attack as lasting from a fraction of a second up to two minutes. Many people have dozens of attacks per day with pain-free gaps in between. This pattern is called paroxysmal pain.[6][8]
In atypical trigeminal neuralgia, sometimes called type 2, patients also feel a constant burning sensation between attacks. This form is harder to treat and may overlap with atypical facial pain. It is often more refractory to standard anticonvulsants and to microvascular decompression than classic trigeminal neuralgia, and patients with atypical symptom patterns have a significantly higher rate of surgical relapse.[8][10]
The pain follows the branches of the trigeminal nerve. It most often strikes the maxillary branch (cheek and upper teeth) or the mandibular branch (jaw and lower teeth). The ophthalmic branch (forehead and eye) is involved less often. A brief facial spasm or muscle twitch can appear at the moment of pain, which is why the older name tic douloureux (painful twitch) is still used. A visible facial spasm during an attack supports the diagnosis.[6][8]
Common Triggers
- Brushing teeth or flossing
- Shaving or applying makeup
- Eating, drinking, or swallowing
- Talking, smiling, or laughing
- Cold air or wind on the face
- Light touch to a small area on the cheek or lip
How It Is Diagnosed
Diagnosis is clinical and based on the pattern of pain, using International Headache Society criteria. A neurological exam helps rule out other problems. A high-resolution MRI is recommended in nearly every case to look for vascular compression, tumors, or signs of multiple sclerosis. 3D heavily T2-weighted sequences (also called steady-state free precession) and MR angiography are the gold standard for visualizing neurovascular conflict at the nerve root.[6][7][8] Blood tests and a dental exam may also be ordered to rule out infections or tooth-related pain. Some patients may report trigeminal neuralgia ear pain because the mandibular branch (V3) extends toward the auriculotemporal area, so a careful exam, and sometimes an ENT review, can separate it from middle ear or TMJ-related pain.
Treatment Options
Treatment usually starts with medication and moves to procedures or surgery only if drugs stop working or cause side effects.[6][8]
| Option | Type | Initial relief | Long-term relief | Recovery | Key consideration |
|---|---|---|---|---|---|
| Carbamazepine / oxcarbazepine | First-line medication | 70-80% | Falls over time | Days | FDA Black Box; HLA-B*1502 testing in Asian patients[13][14] |
| Microvascular decompression | Open brain surgery | 87-98% | 66-68% at 10 yrs | 4-6 wks | Best for healthy patients with proven vascular compression on MRI[2][8][15] |
| Percutaneous procedure (balloon, glycerol, RFL) | Needle through cheek to ganglion | High, fast | 25-50% recurrence within 3-4 yrs | 1-2 wks | Often chosen for older patients; some lasting numbness[6][8] |
| Stereotactic radiosurgery (gamma knife) | Focused radiation, no incision | Gradual, ~30 days median | Up to 45% recur at median 4 yrs | None | No incision; effect develops over 8-12 weeks[6][8] |
| Nerve block / neurostimulation | Adjunct or refractory care | Variable | Variable | Days | Reserved for refractory cases[8] |
Medications
Carbamazepine is the only medication FDA-approved specifically for trigeminal neuralgia and remains the gold standard first-line treatment. Oxcarbazepine is widely used as an equally effective alternative with a slightly more favorable side-effect profile.[6][8] These anticonvulsant drugs calm the misfiring trigeminal nerve and reduce attacks, with relief sometimes appearing within 24 to 48 hours. Research shows they provide meaningful relief in about 70-80% of patients at first, though effectiveness can fade after months or years as the disease progresses or tolerance develops.[6][8]
Common side effects include drowsiness, dizziness, nausea, and unsteady balance. Doctors typically start with one drug at a low dose and adjust slowly.[6][8]
Carbamazepine carries an FDA Black Box Warning for two serious risks that every patient should understand before starting therapy.[13] The first is severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, which can be life-threatening. These reactions are far more common in patients who carry a genetic marker called HLA-B*1502, which is most often found in people of Han Chinese and other Asian ancestry. The FDA recommends genetic testing for HLA-B*1502 before starting carbamazepine in patients of Asian descent.[13][14] The second is severe bone marrow depression, including aplastic anemia and agranulocytosis, which can sharply lower red and white blood cell counts. Patients on carbamazepine need regular blood tests so any drop is caught early. Carbamazepine should not be used with MAO inhibitor antidepressants or in patients with a history of bone marrow problems.[13]
Both carbamazepine and oxcarbazepine can also cause hyponatremia (low blood sodium) and liver enzyme abnormalities. For that reason, monitoring during therapy should include not just complete blood counts but also a basic metabolic panel for sodium and liver function tests.[1][8] Patients should report new confusion, headache, fatigue, nausea, dark urine, or yellowing of the skin or eyes promptly.
Other options include lamotrigine, baclofen, pregabalin, topiramate, and phenytoin. Botulinum toxin injections may help in selected cases.[6][8]
Microvascular Decompression
Microvascular decompression is open brain surgery that moves the offending blood vessel away from the trigeminal nerve and places a small cushion between them. Immediate postoperative pain relief is reported in 87% to 98% of patients. At the 10-year mark, overall success rates fall to about 66.8% to 68%, but outcomes depend heavily on what the MRI shows. Patients with severe neurovascular compression maintain about 80% sustained relief at 5 to 10 years, while patients with only mild compression on imaging see closer to 56% sustained relief over the same period.[2][8][15] That makes severity of vascular contact one of the strongest predictors of long-term success and a key part of the surgical decision. Risks include hearing loss in roughly 0.2% to 4.5% of patients, facial numbness, and rare serious complications.[2][8][15] Microvascular decompression is most appropriate for healthier patients with proven vascular compression on MRI.[2][3]
Long-term success is meaningfully lower in patients with multiple sclerosis or atypical (type 2) symptoms, who experience higher relapse rates than patients with classic trigeminal neuralgia.[2][8]
Percutaneous Procedures
A percutaneous procedure treats the nerve through a thin needle passed through the cheek into the trigeminal ganglion. There are three common types: balloon compression, glycerol injection, and radiofrequency lesioning (also called rhizotomy). Each percutaneous procedure offers fast pain relief and a short recovery, but pain often returns within a few years and many patients have some lasting facial numbness.
Recurrence rates are higher and earlier than with microvascular decompression. Roughly 25% of patients experience returning pain within 1 to 3 years, and up to 50% experience recurrence by 3 to 4 years after a single procedure.[6][8] A percutaneous procedure is often chosen for older patients or those who cannot undergo open craniotomy. Pain relief from a single percutaneous procedure typically lasts 1 to 5 years before another treatment is needed, and many patients undergo more than one procedure over their lifetime.[6]
Stereotactic Radiosurgery
Stereotactic radiosurgery, often called gamma knife, uses focused radiation to damage a small target on the trigeminal nerve at the brainstem without an incision. Stereotactic radiosurgery offers pain relief in many patients, but the full effect is gradual, with a median time to pain cessation of about 30 days and the full effect taking 8 to 12 weeks to develop. Stereotactic radiosurgery has fewer immediate risks than open surgery, though pain may return over time, with up to 45% of patients experiencing recurrence at a median follow-up of 4 years.[6][8]
Nerve Blocks and Neurostimulation
A nerve block can offer short-term relief and help confirm the source of pain. Neurostimulation devices, including peripheral neurostimulation of trigeminal branches, are being studied for patients who do not respond to other treatments.[8] Results vary, and these options are typically reserved for refractory cases.
Recovery and Aftercare
Recovery depends on the treatment chosen, ranging from days for medication adjustments to several weeks for brain surgery.[6]
Patients on medication usually feel some relief within days but need regular follow-up visits and lab work to manage side effects, especially while on carbamazepine. Recommended labs include complete blood counts, sodium levels, and liver function tests. Doses are adjusted slowly to find the lowest effective amount.[1][6][8][13]
Microvascular decompression is a posterior fossa craniotomy, so most patients spend time in intensive care monitoring before moving to a regular room. Hospital stays last 2 to 5 days, and full recovery takes about 4 to 6 weeks. Most patients return to light activity within 2 to 3 weeks.[2][8] After a percutaneous procedure, recovery is faster, often 1 to 2 weeks, but some facial numbness is expected and may be permanent.
After stereotactic radiosurgery, there is no incision to heal, but pain relief is gradual over weeks to months. In all cases, follow-up visits and repeat MRI scans help track results and catch any return of pain early. Many patients also benefit from sleep support and counseling, since chronic pain often disrupts both.
Cost Factors
Treatment costs range from low monthly medication co-pays to tens of thousands of dollars for surgery, depending on the option chosen.
Generic carbamazepine and oxcarbazepine often cost $10-50 per month with most insurance plans. Specialty consultations and MRI imaging may cost $200-2,500 out of pocket if not covered.
A widely cited cost-effectiveness analysis of Medicare claims data from 2011 reported average procedure costs of about $3,910 for percutaneous stereotaxic rhizotomy, $38,062 for stereotactic radiosurgery, and $40,434 for microvascular decompression.[16][17] Because these figures are more than a decade old and US healthcare costs have continued to rise, current 2025-2026 clinic estimates run higher: roughly $4,000 for glycerol rhizotomy up to $10,000-15,000 for balloon compression depending on facility, $30,000-40,000 for stereotactic radiosurgery, and $40,000-100,000+ for microvascular decompression once extended hospital stays or complications are factored into total billed charges. Published cash-pay rates from major academic centers fall in the middle of that range, around $45,000 for microvascular decompression at programs such as Johns Hopkins.[6][8]
Most US insurance plans, including Medicare, cover trigeminal neuralgia treatments when documented as medically necessary. Although microvascular decompression has the highest upfront cost, research suggests it is the most cost-effective option per quality-adjusted life year (QALY) over time for healthy patients with classic trigeminal neuralgia. The 2011 Medicare claims analysis found that microvascular decompression yielded the highest QALY value (about 8.2) among the three main surgical options, driven by its lower recurrence rate and reduced need for repeat procedures.[2][8][16][17] Hospital financial counselors can help with payment plans or charity care for surgical procedures.
When to See a Specialist
Patients with suspected trigeminal neuralgia should see an orofacial pain specialist or a neurologist, not a general dentist alone.[10][11]
Orofacial pain is now a recognized dental specialty. These clinicians are trained to tell trigeminal neuralgia apart from toothaches, TMJ disorders, and other facial pain conditions.[10][11] Many trigeminal neuralgia patients undergo unnecessary tooth extractions, root canals, or dental treatments before they reach the right diagnosis, which is why specialty care matters.[9][10]
Visit the orofacial-pain page to learn how these specialists evaluate facial pain. A general dentist still plays a useful role by ruling out tooth and gum causes first, then referring patients with nerve-pattern pain to the right specialist.
Find a Specialist
If you have brief, electric-shock-like facial pain or have been told a tooth might be the cause but treatment has not helped, an orofacial pain specialist can review your symptoms and order the right imaging. Use this directory to find a specialist near you who works with trigeminal neuralgia and other facial nerve conditions.
Search Orofacial Pain Specialists in Your Area